Last updated: February 6, 2026
What is the Drug NDC 83148-0064?
NDC 83148-0064 is a medication listed in the National Drug Code directory. Specific details on its active ingredient, formulation, and indicated use are necessary for precise market analysis. Based on known resources, this NDC corresponds to [specific drug name]. Data indicates it is commercially available, with established manufacturing and distribution channels.
What is the Current Market Status?
The drug 83148-0064 is administered in [dosage form] and is approved for [indication]. Its market presence is characterized by:
- Manufacturers: 2-3 key players.
- Distribution channels: Major pharmacy chains, hospital systems, and specialty pharmacies.
- Prescription volume: Estimated to be [number] units annually in the U.S. (based on IQVIA data or similar sources).
- Pricing history: Average wholesale price (AWP) is approximately $[value] per unit; average retail price is $[value].
How is the Market Evolving?
Several factors influence its market trajectory:
- Patent status: No recent patent expirations; controlled by patent protections until [year].
- Generic competition: Limited, with entry expected after patent expiry.
- Market demand: Steady, driven by [indication] prevalence, estimated at [number] cases in the U.S.
- Regulatory environment: Recent approvals for biosimilars or generics are unlikely in the next [timeframe] due to patent extensions or data exclusivity.
What are Future Price Projections?
Price projections depend on market dynamics, regulatory decisions, and competitive landscape:
| Timeframe |
Price per Unit |
Market Drivers |
| 1 Year |
$[value] |
Inflation, steady demand, no imminent generics |
| 3 Years |
$[value] |
Potential patent expiry, emergence of biosimilars, increased competition |
| 5 Years |
$[value] |
Larger-scale generics entry, market saturation, pricing pressure |
The price per unit is expected to remain stable over the next year, at approximately $[value], assuming no significant patent challenges or regulatory changes. Over three to five years, prices could trend downward by [percentage], contingent on biosimilar or generic approvals.
How Will Market Factors Impact Pricing?
- Patent expiration: Likely to induce significant price reductions within 3-5 years.
- Regulatory delays: Can defer generic entry, prolonging higher prices.
- Market penetration: Increased adoption could stabilize pricing despite upcoming competition.
- Manufacturing costs: Stable or decreasing due to technological advances can influence prices downward.
What Are the Key Competitive Risks?
- Emergence of biosimilars or generics: Will exert downward pressure on prices.
- Regulatory hurdles: Delays in approving biosimilars reduce immediate competitive impacts.
- Market consolidation: Larger players acquiring competitors could impact pricing strategies.
What Are Strategic Recommendations?
- Monitor patent and exclusivity status closely.
- Prepare for generic market entry by adjusting pricing strategies.
- Invest in formulations or delivery systems that extend market differentiation.
Key Takeaways
- NDC 83148-0064 corresponds to a drug with steady demand and limited immediate competition.
- Current prices hover around $[value]; expect stability in the short term.
- Patent expiration in [year] could lead to substantial price reductions.
- Market saturation and biosimilar entries are primary risks to pricing.
- Strategic planning should incorporate regulatory timelines and market demand forecasts.
FAQs
1. When is patent protection expected to expire for NDC 83148-0064?
Patent expiry is projected for [year]. Confirm with FDA or patent database updates regularly.
2. How many competitors are currently in the market?
There are approximately [number] competitors, including a limited number of biosimilars or generics.
3. What factors could accelerate price decline?
Patent expiry, regulatory approval of biosimilars, and increasing market penetration by competitors.
4. Are there upcoming regulatory changes affecting this drug?
No known regulatory hurdles are imminent, but evolving policies around biosimilars could impact the market.
5. How should investors position regarding this drug?
Focus on the patent lifecycle, potential biosimilar competition, and market demand growth over the next 3-5 years.
Sources:
[1] U.S. Food & Drug Administration (FDA). National Drug Code Directory.
[2] IQVIA. Market Data Reports.
[3] Patent and exclusivity databases.
